Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma.
暂无分享,去创建一个
[1] P. Moore,et al. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and those without HIV infection. , 1995, The New England journal of medicine.
[2] D. Ganem. AIDS: Viruses, cytokines and Kaposi's sarcoma , 1995, Current Biology.
[3] M. Kaplan,et al. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma , 1995, The Lancet.
[4] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.
[5] E. Cesarman,et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. , 1994, Science.
[6] M. Raffeld,et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma , 1994, Nature.
[7] I. Thior,et al. Reduced rate of disease development after HIV-2 infection as compared to HIV-1. , 1994, Science.
[8] H. Whittle,et al. The effects of HIV‐2 infection in a rural area of Guinea‐Bissau , 1994, AIDS.
[9] S. Chevret,et al. Provirus copy number to predict disease progression in asymptomatic human immunodeficiency virus type 1 infection. , 1994, The Journal of infectious diseases.
[10] H. Gayle,et al. Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. , 1993, JAMA.
[11] F. Brun-Vézinet,et al. Cellular and plasma viral load in patients infected with HIV‐2 , 1993, AIDS.
[12] H. Whittle,et al. The epidemiology of HIV infection in a rural area of Guinea‐Bissau , 1993, AIDS.
[13] S. Bloor,et al. Variable relationship between proviral DNA load and infectious virus titre in the peripheral blood mononuclear cells of HIV‐1‐infected individuals , 1993, AIDS.
[14] J. Albert,et al. Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection. , 1993, Virology.
[15] P. Wingfield,et al. Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation , 1993, Journal of virology.
[16] L. Buonaguro,et al. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. , 1992, Journal of immunology.
[17] J. Garson,et al. Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of 'nested' PCR products. , 1992, Journal of virological methods.
[18] R. Kurth,et al. Quantitation of a lentivirus in its natural host: simian immunodeficiency virus in African green monkeys , 1992, Journal of virology.
[19] F. Jensen,et al. Quantitation of HIV viral burden by PCR in HIV seropositive Navy personnel representing Walter Reed stages 1 to 6. , 1992, AIDS research and human retroviruses.
[20] R. Gallo,et al. Pathogenesis of AIDS-associated Kaposi's sarcoma. , 1991, Hematology/oncology clinics of North America.
[21] B. Saltzman,et al. Kaposi's sarcoma in HIV-negative homosexual men , 1990, The Lancet.
[22] S. Nakamura,et al. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. , 1989, Science.
[23] S. Nakamura,et al. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. , 1988, Science.
[24] S. Nakamura,et al. Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4+ T cells. , 1988, Science.
[25] J. Ziegler. Pathogenesis of AIDS-associated Kaposi's sarcoma. , 1988, Lymphology.
[26] J. Ziegler,et al. The value of a clinical definition for epidemic KS in predicting HIV seropositivity in Africa. , 1991, Journal of acquired immune deficiency syndromes.
[27] M. Hutt. The epidemiology of Kaposi's sarcoma. , 1981, Antibiotics and chemotherapy.